Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma

Genes Chromosomes and Cancer

Volumn 45, Issue 12, 2006, Pages 1111-1120

  Chng, Wee J ^a   Ketterling, Rhett P ^b   Fonseca, Rafael ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CHROMOSOME 11; CHROMOSOME 15; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME INVERSION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC DAMAGE; GENOMIC INSTABILITY; HETEROZYGOSITY; HUMAN; HYPERDIPLOID MYELOMA; KARYOTYPE; MOLECULAR CLONING; MOLECULAR EVOLUTION; MONOSOMY; MYELOMA; PREVALENCE; PRIORITY JOURNAL; TRISOMY;

CHROMOSOME ABERRATIONS; DATABASES, GENETIC; HUMANS; KARYOTYPING; MODELS, GENETIC; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC;

EID: 33751108537     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20375     Document Type: Article

References (30)

1. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. 2001. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12:1315-1328.
2. Avet-Loiseau H, Andree-Ashley LE, Moore D, II, McIlerin MP, Feusner J, Bataille R, Pallavicini MG. 1997. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosomes Cancer 19:124-133.
3. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J, Jr. 2005. Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma. Blood 106:296-303.
4. Chng WJ, Santana-Davila R, Van Wier SA, Ahmann GJ, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Jacobus S, Blood E, Oken MM, Henderson K, Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A, Greipp PR, Fonseca R. 2006. Prognostic factors for hyperdiploid-myeloma: Effects of chromosome 13 deletions and IgH translocations. Leukemia 20:807-813.
5. Chng WJ, Van Wier SA, Ahmann GJ, Winkler JM, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Oken MM, Blood E, Henderson K, Santana-Davila R, Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A, Greipp PR, Fonseca R. 2005. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS. Blood 106:2156-2161.
6. Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC, Chaganti RS. 1998. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 91:3007-3010.
7. Debes-Marun CS, Dewald CW, Bryant S, Picken E, Santana-Davila R, Gonzalez-Paz N, Winkler JM, Kyle RA, Gertz JM, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA, Greipp PR, Fonseca R. 2003. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia 17:427-436.
8. Duesberg P, Stindl R, Hehlmann R. 2000. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci USA 97:14295-14300.
9. Fabarius A, Hehlmann H, Duesberg PH. 2003. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet Cytogenet 143:59-72.
10. Fauth C, O'Hare MJ, Lederer G, Jat PS, Speicher MR. 2004. Order of genetic events is critical determinant of aberrations in chromosome count and structure. Genes Chromosomes Cancer 40:298-306.
11. Fonseca R, Barlogie B, Bataille K, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD, Jr., Stewart AK, Avet-Loisean H. 2004. Genetics and cytogenetics of multiple myeloma: A workshop report. Cancer Res 64:1546-1558.
12. Fonseca R, Debes-Marun CS, Pieken EB, Dewald GW, Bryant SC, Winkler JM, Blood E, Oken MM, Santana-Davila R, Gonzalez-Paz N, Kyle RA, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR. 2003. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood 102:2562-2567.
13. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437:1043-1047.
14. Gisselsson O, Jonson F, Petersen A, Strombeck B, Dal Cin P, Doglund M, Mitelman F, Mertens F, Mandahl N. 2001. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 98:12683-12688.
15. Gisselsson D, Pettersson L, Hoglund M, Heidenblad M, Gorunova L, Wiegant J, Mertens F, Dal Cin P, Mitelman F, Mandahl N. 2000. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97:5357-5362.
16. Gutierrez NC, Garcia JL, Hernandez JM, Lumbreras E, Castellanos M, Rasillo A, Mateo C, Hernandez JM, Perez S, Orfao A, San Miguel JF. 2004. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood 104:2661-2666.
17. Hoglund M, Gisselsson D, Mandahl N, Johansson B, Mertens F, Mitelmun F, Sall T. 2001. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31:156-171.
18. Hoglund M, Gisselsson D, Sall T, Mitelman F. 2002. Coping with complexity. Multivariate analysis of tumor karyotypes. Cancer Genet Cytogenet 135:103-109.
19. Hoglund M, Frigyesi A, Sall T, Gisselsson D, Mitelman F. 2005. Statistical behavior of complex cancer karyotypes. Genes Chromosomes Cancer 42:327-341.
20. Horsman DE, Okamoto I, Ludkovski O, Le N, Harder L, Gesk S, Siebert R, Chhanabhai M, Sehn L, Connors JM, Gascoyne RD. 2003. Follicular lymphoma lacking the t(14;18)(q32;q21): Identification of two disease subtypes. Br J Haematol 120:424-433.
21. ISCN. 1995. Mitelman F, editor. An International System for Human Cytogenetic Nomenclature (1995). Basel: S. Karger AG.
22. Meraldi P, Honda R, Nigg EA. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 21:483-492.
23. Mitelman F, Johansson B, Mertens F. 2006. Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/chromosomes/mitelman.
24. Nilsson T, Hoglund M, Lenhoff S, Rylander L, Turesson I, Westin J, Mitelman F, Johansson B. 2003. A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. Br J Haematol 120:960-969.
25. Shi Q, King RW. 2005. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437:1038-1042.
26. Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C. 2001. Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98:2229-2238.
27. Smadja NV, Fruchart C, Isnard F, Louvet C, Dutel JL, Cheron N, Grange MJ, Monconduit M, Bastard C. 1998. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases. Leukemia 12:960-969.
28. Storchova Z, Pellman D. 2004. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45-54.
29. Wu KD, Orme LM, Shanghnessy J, Jr., Jacobson J, Barlogie B, Moore MA. 2003. Telomerase and telomere length in multiple myeloma: Correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 101:4982-4989.
30. Zandecki M, Lai JL, Genevieve F, Bernardi K, Volle-Remy H, Blanchet O, Francois M, Cosson A, Bauters F, Facon T. 1997. Several cytogenetic subcloncs may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood 90:3682-3690.